Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Gorham-Stout disease is classified under ICD-10 code M85.4 (solitary bone cyst) or more specifically M85.5 (aneurysmal bone cyst) in many clinical settings, though it is often coded as Q87.3 for congenital malformation syndromes; it does not have a dedicated, unique ICD-9 code and is typically categorized under 733.99 (other specified disorders of bone and cartilage). Because it is an extremely rare condition characterized by massive osteolysis, precise coding often requires consultation with a medical coder to ensure accurate documentation for insurance and research purposes. What is the clinical classification of Gorham-Stout disease? Gorham-Stout disease, also known as "vanishing bone disease," is a rare skeletal disorder characterized by the uncontrolled proliferation of vascular channels, which leads to the progressive resorption and destruction of bone matrix.
TL;DR: Gorham-Stout disease is classified under ICD-10 code M85.4 (solitary bone cyst) or more specifically M85.5 (aneurysmal bone cyst) in many clinical settings, though it is often coded as Q87.3 for congenital malformation syndromes; it does not have a dedicated, unique ICD-9 code and is typically categorized under 733.99 (other specified disorders of bone and cartilage). Because it is an extremely rare condition characterized by massive osteolysis, precise coding often requires consultation with a medical coder to ensure accurate documentation for insurance and research purposes.
Gorham-Stout disease, also known as "vanishing bone disease," is a rare skeletal disorder characterized by the uncontrolled proliferation of vascular channels, which leads to the progressive resorption and destruction of bone matrix. Because Gorham-Stout disease is so rare—with fewer than 300 cases reported in medical literature—it lacks a single, disease-specific code in older systems. Clinicians managing Gorham-Stout disease must often use broader diagnostic codes that reflect the primary manifestation, such as bone cysts or vascular malformations, to facilitate billing and clinical tracking.
The diagnosis of Gorham-Stout disease is one of exclusion, as there is no single laboratory test to confirm it. Physicians typically combine clinical findings, radiographic imaging, and histopathological analysis. When a patient presents with unexplained bone resorption, the following diagnostic pathway is generally followed:
Current medical research indicates that Gorham-Stout disease is not considered an inherited genetic condition. While the exact etiology remains unknown, the consensus among researchers is that it is a sporadic, non-hereditary disorder. There is no evidence of a direct genetic mutation passed from parents to children, which provides some reassurance to families concerned about the recurrence risk for siblings or future generations. At DiseaseMaps.org, 10 people with Gorham-Stout disease have joined our community to share their experiences, noting that the journey to diagnosis is often long due to the disease's sporadic nature.
For patients and caregivers, understanding that Gorham-Stout disease lacks a specific, dedicated ICD code can be frustrating. Medical billing relies on these codes for authorization of treatments, such as bisphosphonates, radiation therapy, or surgical stabilization. When working with your healthcare provider, it is essential to ensure that the documentation clearly describes the "massive osteolysis" and "vascular malformation" aspects of Gorham-Stout disease, as these descriptive terms help justify the medical necessity of specialized care.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.